Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

by Nakamura, Ikuo, Zakharia, Kais, Banini, Bubu A., Mikhail, Dalia S., Kim, Tae Hyo, Yang, Ju Dong, Moser, Catherine D., Shaleh, Hassan M., Thornburgh, Sarah R., Walters, Ian, Roberts, Lewis R.
Published 2014

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

by Nakamura, Ikuo, Zakharia, Kais, Banini, Bubu A., Mikhail, Dalia S., Kim, Tae Hyo, Yang, Ju Dong, Moser, Catherine D., Shaleh, Hassan M., Thornburgh, Sarah R., Walters, Ian, Roberts, Lewis R.
Published 2015

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

by Asgharpour, Amon, Cazanave, Sophie C., Pacana, Tommy, Seneshaw, Mulugeta, Vincent, Robert, Banini, Bubu A., Kumar, Divya Prasanna, Daita, Kalyani, Min, Hae-Ki, Mirshahi, Faridoddin, Bedossa, Pierre, Sun, Xiaochen, Hoshida, Yujin, Koduru, Srinivas V., Contaifer, Daniel, Warncke, Urszula Osinska, Wijesinghe, Dayanjan S., Sanyal, Arun J.
Published 2016